EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $259,000 | -74.8% | 20,871 | -87.5% | 0.05% | -60.7% |
| Q4 2018 | $1,029,000 | +11.0% | 167,035 | +126.2% | 0.14% | +264.9% |
| Q4 2017 | $927,000 | -30.4% | 73,854 | +5.7% | 0.04% | -70.9% |
| Q3 2017 | $1,331,000 | +123.7% | 69,876 | +77.3% | 0.13% | +135.2% |
| Q2 2017 | $595,000 | +80.9% | 39,406 | +44.9% | 0.05% | +35.0% |
| Q4 2016 | $329,000 | -82.1% | 27,195 | -85.5% | 0.04% | -80.1% |
| Q3 2016 | $1,840,000 | +196.8% | 186,948 | +208.7% | 0.20% | +157.7% |
| Q2 2016 | $620,000 | – | 60,556 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |